Renal Colic

MONDAY, July 15, 2024 -- For patients presenting with acute pain, the quantity of opioids consumed during two weeks after emergency department discharge is low and varies across pain conditions, according to a study published online July 15 in CMAJ , the journal of the Canadian Medical Association. Raoul Daoust, M.D., from Sacré-Coeur Hospital in Montreal, and colleagues conducted a prospective, multicenter cohort study involving 2,240 adults (mean age, 51 years) with an acute pain condition present for less than two weeks who were discharged from the emergency department with an opioid prescription. Participants completed a pain medication diary for real-time recording of all analgesics consumed during a 14-day follow-up. The researchers found that participants consumed a median of five morphine 5-mg tablet equivalents over 14 days, with significant variation seen across pain conditions. Overall, 63 percent of the opioid tablets prescribed were unused. Those experiencing renal colic or abdominal pain required fewer opioid tablets (eight morphine 5-mg tablet equivalents) than those with fractures, back pain, neck pain, or other musculoskeletal pain (24, 21, 17, and 16 tablets, respectively) to meet the opioid need of 80 percent of patients for two weeks. "Our findings may provide guidance to enable clinicians to prescribe lower quantities of opioids and provide them in even smaller portions tailored to the specific cause of acute pain, thereby allowing adequate pain relief while reducing the risk of opioid misuse," the authors write. One author disclosed ties to the medical device industry. Abstract/Full Text Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.

An ureteroscope is an endoscope designed to work and view within the ureter. Other opportunities frequently used by endourologists and urologists is in incorporating the nephroscope and cystoscope. Even though such opportunities now allow modern surgical stone treatment, they have been routinely used for the last few years. The use of ureteroscopy is on the rise for the treating ureteral calculi during pregnancy and for persistent renal colic patients without ureteral calculi detected in ultrasound. This treatment may cause a clinical dilemma owing to the possible risks for both the fetus and mother. The study by TMR Research (TMR) intends to inform on the rapid evolution and projections of the global ureteroscopy devices market in detail. The study also emphasizes on competitor dynamics of the market by factoring in strength and weaknesses of well-known market players. Get Brochure of the Report @ Global Ureteroscopy Devices Market: Drivers & Restraints The development of global ureteroscopy devices market rides mainly on the continual growth in the area of ureteroscopy, interrupted by improvements in imaging tech. The rising acceptance of digital flexible ureteroscope is an essential growth highlighting development of the global ureteroscopy devices market. Including high-quality digital image sensors in the product has been sustaining striking improvements in ureteroscopy devices market. This has already improved surgical outcomes of ureteroscopy devices in the removal of stones. The growing practice of flexible ureteroscopy devices among urologists to treat and diagnose lesions of the upper urinary tract is a prime aspect driving the global market. Moreover, the significant demand for minimally-invasive methods in urinary calculus diseases is a prime aspect emphasizing growth in the global ureteroscopy devices market. New methods for surgical management of urolithiasis for the past few years are projected to make a way for exciting, new avenues in the global ureteroscopy devices market. However, the high cost of reusable and digital ureteroscopy devices might hinder demand in the global ureteroscopy devices market. Nevertheless, the market will be benefitted by adopting minimally invasive methods in managing the rising incidence of urologic diseases in young adults. Global Ureteroscopy Devices Market: Market Potential The LithoVue Empower Retrieval Deployment Device is launched by Boston Scientific in the Europe and North America for retrieval of kidney stones through flexible ureteroscopy (URS). This device was developed due to a need to enhance the procedural bottlenecks during kidney stone removal methods. The device aims to address and identify unmet needs for evolution of treatment of urologic and pelvic conditions, enhance quality of care, advance patient outcomes, and reduce procedural costs. Such aspects are expected to promote growth in the global ureters copy devices market. Buy this Premium Report @ Global Ureteroscopy Devices Market: Geographical Outlook Significant growth for ureteroscopy devices is observed in the North America. The growth is fueled by the extensive uptake of ureteroscopy devices in non-invasively treating urolithiasis among patient populations and the recent launch of innovative products. Europe is the second largest market for ureteroscopes owing to rapidly growing aging population demanding advanced medical devices, increasing number of kidney stone treatment procedures, favorable reimbursement policies, and presence of key players with strong distribution channels in the Germany and other parts of Western Europe. Global Ureteroscopy Devices Market: Competitive Landscape The global ureteroscopy devices market is highly fragmented and the key players are introducing various strategies to maintain a significant position in the global ureteroscope market. Some of them include new product launches, cost effective and efficient, mergers and acquisitions. Some of the prominent companies in the global ureteroscopy devices market include Boston Scientific Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, PENTAX Medical, and Stryker. Get Table of Content of the Report @ READ EXCLUSIVE PRESS RELEASES AND ARTICLES: About TMR Research TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Contact: Rohit Bhisey TMR Research, 3739 Balboa St # 1097, San Francisco, CA 94121 United States Tel: +1-415-520-1050 Visit Site: